Education
About Us
Working with TipRanks
Follow Us
Enzo Biochem, Inc. (ENZB)
:ENZB
ENZB Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.25 - $1.19
Previous CloseN/A
VolumeN/A
Average Volume (3M)688.74K
Market Cap
$35.76M
Enterprise Value$1.97M
Total Cash (Recent Filing)$36.69M
Total Debt (Recent Filing)$3.00M
Price to Earnings (P/E)―
Beta1.91
Next Earnings
Oct 21, 2025EPS EstimateN/A
Last Dividend Ex-Date
Nov 15, 2024Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding52,432,130
10 Day Avg. Volume64,201
30 Day Avg. Volume688,735
Financial Highlights & Ratios
PEG Ratio-0.69
Price to Book (P/B)0.82
Price to Sales (P/S)0.00
P/FCF Ratio-2.18
Enterprise Value/Market Cap0.06
Enterprise Value/Revenue0.02
Enterprise Value/Gross Profit0.16
Enterprise Value/Ebitda-0.09
Forecast
1Y Price Target
$0.50Price Target Upside-26.47% Downside
Rating ConsensusHold
Number of Analyst Covering0
Enzo Biochem News
PremiumCompany Announcements
Enzo Biochem Announces Special Meeting for Proposed Merger
PremiumCompany Announcements
Enzo Biochem Announces Merger with Battery Ventures
PremiumCompany Announcements
Enzo Biochem Reports Revenue Decline and Net LossOwnership Overview
12.07%
Insiders
4.26%
Mutual Funds
13.44% Other Institutional Investors
70.23% Public Companies and
Individual Investors
ENZB FAQ
What was Enzo Biochem, Inc.’s price range in the past 12 months?
Enzo Biochem, Inc. lowest stock price was $0.25 and its highest was $1.19 in the past 12 months.
What is Enzo Biochem, Inc.’s market cap?
Enzo Biochem, Inc.’s market cap is $35.76M.
When is Enzo Biochem, Inc.’s upcoming earnings report date?
Enzo Biochem, Inc.’s upcoming earnings report date is Oct 21, 2025 which is in 88 days.
How were Enzo Biochem, Inc.’s earnings last quarter?
Enzo Biochem, Inc. released its earnings results on Jun 16, 2025. The company reported -$0.053 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.053.
Is Enzo Biochem, Inc. overvalued?
According to Wall Street analysts Enzo Biochem, Inc.’s price is currently Overvalued.
Does Enzo Biochem, Inc. pay dividends?
Enzo Biochem, Inc. pays a Notavailable dividend of $0.1 which represents an annual dividend yield of N/A. See more information on Enzo Biochem, Inc. dividends here
What is Enzo Biochem, Inc.’s EPS estimate?
Enzo Biochem, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enzo Biochem, Inc. have?
Enzo Biochem, Inc. has 52,432,130 shares outstanding.
What happened to Enzo Biochem, Inc.’s price movement after its last earnings report?
Enzo Biochem, Inc. reported an EPS of -$0.053 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.263%.
Which hedge fund is a major shareholder of Enzo Biochem, Inc.?
Currently, no hedge funds are holding shares in ENZB
Enzo Biochem Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$0.50 (-26.47% Downside)
$0.50 (-26.47% Downside)
Blogger Sentiment
Bullish
ENZB Sentiment 70%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-36.08%
12-Months-Change
Fundamentals
Return on Equity
-13.95%
Trailing 12-Months
Asset Growth
-32.05%
Trailing 12-Months
Company Description
Enzo Biochem, Inc.
Enzo Biochem, Inc. (ENZB) is a life sciences and biotechnology company specializing in the development, manufacture, and sale of innovative products and technologies for research, diagnostics, and therapeutics. The company operates primarily through two segments: Enzo Clinical Labs and Enzo Life Sciences. Enzo Clinical Labs provides a full range of clinical laboratory and pathology services, while Enzo Life Sciences develops, manufactures, and markets reagents, assays, and systems used in medical research and drug development.